The Leuven Cancer Institute (LKI) is the largest cancer institute in Belgium. It was founded as a collaboration of the University of Leuven (KU Leuven) and the University Hospitals Leuven (UZ Leuven).
In the LKI, basic scientists, clinical researchers and physicians actively join forces to intensify the battle against cancer and to improve chances for cancer patients. The LKI is pioneering in the fields of cancer care, diagnosis, therapy, research and training.
There is also special attention to the social and emotional needs of the patients. In 2016, the LKI cared for 34091 cancer patients, provided 22534 chemotherapy sessions and 42250 radiotherapy sessions, and published 819 scientific papers.
Strong assets of the institute are: close proximity of hospital and research facilities on the same campus (ideal for bench to bedside, and back, research), up to date biobanking with clinically documented samples, leading role in many clinical trials, and a set of excellent core facilities (incl. a genomics core for molecular characterisation of tumors).